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Abstract
Arsenic, a toxic metalloid, exists in the natural environment and its organic form is approved for use as a feed
additive for animal production. As a major foodborne pathogen of animal origin,Campylobacter is exposed to
arsenic selection pressure in the food animal production environments. Previous studies showed that
Campylobacter isolates from poultry were highly resistant to arsenic compounds and a 4-gene operon
(containing arsP, arsR, arsC, and acr3) was associated with arsenic resistance in Campylobacter. However, this
4-gene operon is only present in some Campylobacter isolates and other arsenic resistance mechanisms in C.
jejunihave not been characterized. In this study, we determined the role of several putative arsenic resistance
genes including arsB, arsC2, and arsR3 in arsenic resistance in C. jejuni and found that arsB, but not the other
two genes, contributes to the resistance to arsenite and arsenate. Inactivation of arsB in C. jejuni resulted in 8-
and 4-fold reduction in the MICs of arsenite and arsenate, respectively, and complementation of the arsB
mutant restored the MIC of arsenite. Additionally, overexpression of arsB in C. jejuni 11168 resulted in a
16-fold increase in the MIC of arsenite. PCR analysis of C. jejuni isolates from different animals hosts
indicated that arsBand acr3 (the 4-gene operon) are widely distributed in various C. jejuni strains, suggesting
thatCampylobacter requires at least one of the two genes for adaptation to arsenic-containing environments.
These results identify ArsB as an alternative mechanism for arsenic resistance inC. jejuni and provide new
insights into the adaptive mechanisms of Campylobacter in animal food production environments.
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Introduction
Arsenic is a wildly distributed toxic metalloid in water, soil, and
air from natural and anthropogenic sources, and exists in both
inorganic and organic forms [1–3]. The most prevalent inorganic
forms of arsenic include trivalent arsenite [AS(III)] and pentava-
lent arsenate [AS(V)]. The trivalent form is more toxic than the
pentavalent form [1,3]. AS(III) impairs the functions of many
proteins by reacting with their sulfhydryl groups, while AS(V) is
a molecular analog of phosphate, which inhibits oxidative
phosphorylation and harms the main energy-generation system
[2,4]. In order to survive arsenic toxicity, microorganisms have
developed different mechanisms for arsenic detoxification, in-
cluding reduction of AS(V) to AS(III) by arsenate reductases and
methylation or extrusion of AS(III) by efflux transporters [5–7].
The genes encoding arsenic detoxification systems are found on
both plasmids and chromosomes. Usually, the ars genes are
organized as operons, such as arsRBC, arsRABC, and arsRDABC,
but some ars genes exist singly [6,8–14]. ArsC is a small-molecular
mass arsenate reductase, which converts AS(V) to AS(III) in the
cytoplasm [5,15]. As(III) is extruded by AS(III)-specific transpor-
ters, such as ArsB and Acr3 [5,6]. The activity of ArsB can be
ATP-independent or requires the help of ArsA, an ATPase
[16,17]. A recent study identified a new arsenic detoxification
mechanism mediated by ArsM, an AS(III) S-adenosylmethionine
methyltransferase, which methylates AS(III) to volatile trimethy-
larsine [7]. In addition, there are other Ars proteins involved in
arsenic resistance. ArsR, a transcription regulator, modulates the
expression of arsenic resistance genes [6,18–21]. ArsD, an arsenic
metallochaperone, transfers As(III) to ArsA and increases the rate
of arsenic extrusion [7,22–24]. ArsH, an NADPH-flavin mono-
nucleotide oxidoreductase, also contributes to arsenic resistance,
and its detoxification mechanism is probably through oxidation of
arsenite to the less toxic arsenate or reduction of trivalent
arsenicals to volatile arsines that escape from cells [25,26].
Campylobacter is a leading cause of food-borne bacterial diseases
in the United States and other developed countries [27].
Campylobacter infections account for 400 to 500 million cases of
diarrhea each year worldwide [28]. According to a recent CDC
report, campylobacteriosis is estimated to affect over 840,000
people every year in the U. S. [27]. As a zoonotic pathogen,
Campylobacter is highly prevalent in food producing animals,
including both livestock and poultry [29], and is frequently
exposed to antimicrobials used in animal agriculture. Roxarsone
(4-hydroxy-3-nitro-phenylarsonic acid), an organoarsenic com-
pound, is frequently used as a feed additive to improve weight
gain, feed utilization and pigmentation, and control of coccidiosis
in the poultry industry [30]. Organic roxarsone is excreted
through feces and can also be converted into inorganic AS(V) and
AS(III) in the broiler digestive system, and the total arsenic
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concentration in the litter can reach up to 39 mg/kg [31,32]. Due
to the concern with food safety, the manufacturer of roxarsone
voluntarily suspended sale of this product in the U.S. in 2011
(http://www.fda.gov/AnimalVeterinary/SafetyHealth/
ProductSafetyInformation/ucm258313.htm). Given that Campylo-
bacter is prevalent and well adapted in poultry digestive system, this
organism must have the ability to deal with the toxicity of arsenic
compounds used for poultry production.
Recently, Wang et al. identified a 4-gene ars operon, which is
associated with high-level arsenic resistance in Campylobacter [6].
This operon encodes a putative membrane permease (ArsP),
a transcriptional repressor (ArsR), an arsenate reductase (ArsC),
and an efflux protein (Acr3). The expression of the whole operon is
directly regulated by ArsR and is inducible by AS(III) and As(V)
[6]. According to the published whole genome sequences of
Campylobacter, this ars operon is not present in all Campylobacter
strains and how those strains without this ars operon adapt to
arsenic selection is unknown. The first sequenced C. jejuni strain
NCTC 11168 (http://www.lshtm.ac.uk/pmbu/crf/Cj_updated.
art) lacks the previously characterized ars operon [6,33], but three
putative ars genes are present on the chromosome. These include
cj0258 (an arsR homolog and named arsR3 in this study), cj0717 (an
arsC homolog and named arsC2 in this study), and cj1187c (an arsB
homolog and named arsB in this study), and their functions remain
unknown. In this study, we determine the roles of these putative ars
genes in arsenic resistance and found that cj1187c (arsB) contributes
to the resistance to AS(III). In addition, we investigated the
presence of the arsB and acr3 (present in the 4-gene ars operon)
genes in various Campylobacter isolates. The results suggest that
Campylobacter requires at least one of the two genes for adaptation
to arsenic-containing environment.
Materials and Methods
Bacterial Strains and Growth Conditions
The key bacterial strains and plasmids used in this study are
listed in Table 1. Escherchia coli DH5a used for genetic
manipulation was grown in Luria-Bertani (LB) broth or on
Mueller-Hinton (MH) agar. When required for cloning of plasmids
with different selection markers, kanamycin (30 mg/ml), chloram-
phenicol (10 mg/ml), or ampicillin (100 mg/ml) was added to the
culture media. C. jejuni strains were cultured on MH agar or in
MH broth at 42uC microaerobically (5% O2, 10% CO2, and 85%
N2). Kanamycin (30 mg/ml) or chloramphenicol (4 mg/ml) was
supplemented to the media when needed for culturing the mutant
strains that contained a selection marker.
Chemical Compounds and Antibiotics
The chemicals and antibiotics used in this study were purchased
from Sigma-Aldrich Co. LLC (arsenite, arsenate, chlorampheni-
col, kanamycin, ampicillin, copper sulfate, erythromycin, tetracy-
cline, ethidium bromide, azithromycin, ciprofloxacin, florfenicol,
and clindamycin), Thermo Fisher Scientific Inc. (roxarsone,
mercury bichloride, and telithromycin), and Alfa Aesar (anti-
monite).
Antimicrobial Susceptibility Tests
The MICs of various arsenic compounds against C. jejuni strains
were determined using the agar dilution antimicrobial suscepti-
bility testing method according to the protocol from CLSI [34].
The concentrations of arsenic compounds tested in this study
ranged from 0.25 to 256 mg/ml for arsenite, 2 to 2048 mg/ml for
arsenate, and 1 to 512 mg/ml for roxarsone. Briey, Campylobacter
strains grown on blood agar plates for 24 h were inoculated into
Mueller-Hinton broth and then adjusted to a turbidity equivalent
to a 0.5 McFarland standard by a colorimeter. A multipoint
inoculators (a Cathra replicator system) with 1-mm pins (Oxoid,
Inc., Ogdensburg, NY) was used to inoculate approximately
104 CFU of C. jejuni onto Mueller-Hinton agar containing a twofold
dilution series of arsenic compounds and supplemented with 5%
defibrinated sheep blood. The inoculated plates were incubated at
42uC microaerobically (5% O2, 10% CO2, and 85% N2). The
MIC was defined as the lowest concentration that completely
inhibited the visible growth on the plates. The MICs of various
antibiotics against C. jejuni strains were determined using the broth
microdilution method as described previously [35]. Each MIC test
was repeated at least three times.
PCR
All primers used for PCR are listed in Table 2. PCR was
performed in a volume of 50 ml containing 0.2 mM of primers,
250 mM of deoxynucleoside triphosphates, and 1.25 U of
TaKaRa Ex Taq polymerase or Phusion High-Fidelity DNA
Polymerase. The annealing temperature varied from 50uC to
58uC (Table 2) and the elongation time dependent on the expected
size of the products (1 kb/min).
Insertional Mutation of arsB
Primers arsB1929F and arsB1929R (Table 2) were used to
amplify a 1929 bp arsB fragment with the SwaI and XbaI
restriction sites in the middle region of the fragment. The PCR
fragment was cloned into the pUC19 between the EcoRI and SalI
sites, resulting in the construction of pArsB. Primers arsBCat-F
and arsBCat-R (Table 2) were used to amplify the chloramphen-
icol resistance cat gene from pUOA18 using the Phusion High-
Fidelity DNA Polymerase (NEB). After the XbaI digestion, the cat
cassette was ligated to the SwaI and XbaI digested pARSB to
obtain plasmid pArsBcat, which was then transformed into E. coli
DH5a. Suicide vector pArsBcat was introduced into C. jejuni
NCTC 11168 using an electroporator (Gene Pulser Xcell System;
Bio-Rad Laboratories). Transformants were selected on MH agar
containing chloramphenicol at 4 mg/ml. The insertion of cat
cassette into the arsB gene of C. jejuni 11168 was confirmed by PCR
analysis using primers arsB1929F and arsB1929R.
Insertional Mutagenesis of arsC2 (cj0717)
Primers arsC2M1-F and arsC2M1-R were used to amplify the
59 part of arsC2 and its upstream region (arsC2M1), while Primers
arsC2M2-F and arsC2M2-R were used to amplify the 39 part of
arsC2 and its downstream region (arsC2M2). After EcoRI and KpnI
digestion, the arsC2M1 PCR product was cloned into the EcoRI
and KpnI digested pUC19, resulting in the construction of pC2M1.
The digested arsC2M2 PCR product was cloned into the XbaI and
PstI digested pC2M1, resulting in the construction of pC2M1M2.
Primers gidAKanF and gidAKanR (Table 2) were used to amplify
the aphA3 gene encoding kanamycin resistance from pMW10
using the Phusion High-Fidelity DNA Polymerase (NEB). After the
KpnI and XbaI digestion, the Kanr cassette was ligated to the KpnI
and XbaI digested pC2M1M2 to obtain plasmid construct
pC2M1M2Kan, which was then transformed into E. coli DH5a.
Suicide vector pC2M1M2Kan was then electroporated into C.
jejuni NCTC 11168. Transformants were selected on MH agar
plates containing 30 mg/ml of kanamycin. The insertion of the
aphA3 gene into arsC2 in the transformants was confirmed by PCR
using primers arsC2M1-F and arsC2M2-R.
Arsenic Resistance in C. jejuni
PLOS ONE | www.plosone.org 2 March 2013 | Volume 8 | Issue 3 | e58894
Insertional Mutagenesis of arsR3 (cj0258)
Primers arsR3M1-F and arsR3M1-R were used to amplify the
59 part of arsR3 and its upstream region (arsR3M1), while primers
arsR3M2-F and arsR3M2-R were used to amplify the 39 part of
arsR3 and its downstream region (arsR3M2). After EcoRI and KpnI
digestion, the arsR3M1 PCR product was cloned into the EcoRI
and KpnI digested pUC19, resulting in the construction of pR3M1.
The digested arsR3M2 PCR product was cloned into the XbaI and
PstI digested pR3M1, resulting in the construction of pR3M1M2.
As mentioned above, primers gidAKanF and gidAKanR (Table 2)
were used to amplify the aphA3 gene encoding kanamycin
resistance from pMW10 using the Phusion High-Fidelity DNA
Polymerase (NEB). After the KpnI and XbaI digestion, the Kanr
cassette was ligated to the KpnI and XbaI digested pR3M1M2 to
obtain plasmid construct pR3M1M2Kan, which was then
transformed into E. coli DH5a. Suicide vector pR3M1M2Kan
was then electroporated into C. jejuni NCTC 11168. Transfor-
mants were selected on MH agar plates containing 30 mg/ml of
kanamycin. The insertion of the aphA3 gene into arsR3 in the
transformants was confirmed by PCR using primers arsR3M1-F
and arsR3M2-R.
Complementation of the DarsB::Cmr Mutant
The DarsB::Cmr mutant was complemented by inserting a wild-
type copy of arsB between the 16S and 23S rRNAs as described by
Muraoka and Zhang [36]. Briefly, primers comarsB-F and
comarsB-R were used to amplify the intact arsB gene including
its ribosome binding site. The amplicon was digested with XbaI
and cloned into the pRRK plasmid, which contains an aphA3
cassette in the opposite orientation to the ribosomal genes, to
obtain plasmid construct pRRKarsB. The direction of the insertion
was confirmed by primers 16sarsB-F and 16sarsB-R. The
construct with arsB in the same transcriptional direction as the
ribosomal genes was selected and used as the suicide vector to
insert the arsB gene into the chromosome of the arsB mutant. The
complemented strains were selected on MH agar containing
30 mg/ml of kanamycin and were confirmed by PCR using
primers 16sarsB-F and 16sarsB-R.
Overexpression of arsB in C. jejuni NCTC 11168
The suicide plasmid pRRKarsB constructed for complementa-
tion was electroporated into wild-type C. jejuni NCTC 11168 wild
type strain, resulting in the insertion of an extra copy of arsB in the
chromosome. Transformants were selected on MH agar plates
Table 1. Bacterial strains and plasmids used in this study.
Bacterial strain or plasmid Description or relevant genotype Source or reference
Plasmids
pUOA18 E. coli-C. jejuni shuttle vector [48]
pUC19 Cloning vector [49]
pMW10 Promoterless lacZ plasmid [50]
pArsB pUC19+arsB This study
pArsBcat pUC19+arsB::cat This study
pRRK pRR::aphA3 [36]
pRRKarsB pRRK+arsB This study
pC2M1 pUC19+arsC2M1 This study
pC2M1M2 pUC19+arsC2M1+arsC2M2 This study
pC2M1M2Kan pUC19+arsC2M1+aphA3+arsC2M2 This study
pR2M1 pUC19+arsR3M1 This study
pR2M1M2 pUC19+arsR3M1+arsR3M2 This study
pR2M1M2Kan pUC19+arsR3M1+aphA3+arsR3M2 This study
strains
DH5a Plasmid propagation E.coli strain Invitrogen
NCTC 11168 Wild-type C. jejuni [33]
11168DarsB NCTC 11168 derivative, DarsB::Cmr This study
11168DarsC2 NCTC 11168 derivative, DarsC2:: aphA3 This study
11168DarsR3 NCTC 11168 derivative, DarsR3:: aphA3 This study
11168DarsBDarsC2 NCTC 11168 derivative, DarsB::Cmr, DarsC:: aphA3 This study
11168+arsB NCTC 11168 derivative, rrs::arsB This study
11168DarsB+arsB 11168DarsB derivative, rrs::arsB This study
ATCC 33560 Wild-type C. jejuni ATCC
33560DarsB ATCC 33560 derivative, DarsB::Cmr This study
CB5-28 Wild-type C. jejuni [6]
CB5-28DarsB CB5-28 derivative, DarsB::Cmr This study
CB5-28DarsC CB5-28 derivative, DarsC:: aphA3 [6]
CB5-28DarsBDarsC CB5-28 derivative, DarsB::Cmr DarsC:: aphA3 This study
doi:10.1371/journal.pone.0058894.t001
Arsenic Resistance in C. jejuni
PLOS ONE | www.plosone.org 3 March 2013 | Volume 8 | Issue 3 | e58894
containing 30 mg/ml of kanamycin and confirmed by PCR using
primers 16sarsB-F and 16sarsB-R.
Real-time qRT-PCR
To determine if the arsB gene is inducible by arsenic compounds,
C. jejuni NCTC 11168 was cultured in MH broth with or without
added arsenite and arsenate for 20 h. The final concentrations of
arsenite and arsenate in the culture were 0.125, 0.25, and 0.5 times
of their corresponding MIC in NCTC 11168. Total RNA was
extracted from three biological replicate cultures using the RNeasy
mini kit (Qiagen) according to the protocol suppliedwith the product
and further treated with the Turbo DNA-free kit (Ambion) to
eliminate DNA contamination in each preparation. For real-time
quantitative reverse transcription-PCR (qRT-PCR), primers arsB-
F1 and arsB-R1 (Table 2) specific for arsB were designed using the
Primer3 online interface (http://frodo.wi.mit.edu/). Real-time
qRT-PCR analyses were conducted using the iScript one-step
RT-PCR kit with SYBR green (Bio-Rad) along with the MyiQ
iCycler real-time PCR detection system (Bio-Rad, Hercules, CA),
and the16S rRNA gene was used for normalization as described in
a previous publication [37]. Briefly, for each RNA template, to
generate the standard curve for quantification of the target
transcript, a 10-fold dilution series between 25 ng/ml and
0.0025 ng/ml were made and used for RT-PCR. Triplicate
reactions in a volume of 15 ml were performed for each dilution of
the RNA template. Thermal cycling conditions were as follows:
10 min at 50uC, 5 min at 60uC followed by 5 min at 95uC, and then
40 cycles of 10 s at 95uC and 30 s at 58uC. Melt-curve analysis was
performed immediately after the amplification. Each specific
amplicon was verified both by the presence of a single melting
temperature peak and by the presence of a single band of expected
size on agarose gel after electrophoresis. Cycle threshold values were
determined with the MyiQ software (BioRad). The relative changes
(n-fold) of transcription in arsB between the induced and noninduced
samples were calculated using the 22DDCT method as described by
Livak and Schmittgen [38].
Analysis of ars Gene Distribution by PCR
To determine the distribution of the arsB and acr3 genes in
various C. jejuni isolates, arsB-specific primers (arsB56F and
arsB1185R) and acr3-specific primers (cje1733F and cje1733R)
[6] were designed from the genomic sequence of C. jejuni NCTC
11168 and RM1221, respectively, and used in PCR analyses with
the genomic templates of different C. jejuni strains and the Ex Taq
polymerase (TaKaRa Bio Inc., Japan). These C. jejuni isolates were
derived from human, chicken, and turkey.
Results
Genetic Features of arsB, arsC2, and arsR3
The arsB gene encodes a putative arsenic efflux membrane
protein (428 amino acids) and shows amino acid sequence
Table 2. PCR primers used in this study.
Primers Sequence (59R39) Annealing temperature (uC)
arsB1929F ACAAGGAATTCATGGCTATGATTTAGGGC 56
arsB1929R ATCATGTCGACCCATAACTTGTCCTTTCG 56
arsBCat-F CGGTTCTAGATGGAGCGGACAACGAGTAAA 58
arsBCat-R GCTTGGATCAGTGCGACAAACTGGGATT 58
comarsB-F GCCGCTAGCAAGGAGATTTAAATGCTTGCTTTTTTTATTTTTTT 52
comarsB-R GGTGCTAGCTTAGACAATAAGAGCAAAAAGAGAA 52
gidAKanF TATGGTACCCGCTTATCAATATATCTATAGAATG 50
gidAKanR AGCTCTAGAGATAATGCTAAGACAATCACTAAA 50
arsBgidAF CATCATAAACCTCCAACCATT 58
arsBgidAR AAGAACTATCCCAAACCAAG 58
arsR3M1-F TGGGAATTCGAGGCTTTAATCAACACTTA 52
arsR3M1-R TAAGGTACCTTTCATCGGCATTTTCACAT 52
arsR3M2-F CGATCTAGATGTGAAAATGCCGATGAAAA 52
arsR3M2-R ATTCTGCAGACCATGCACTAGCAAAGGAA 52
arsC2M1-F TGGGAATTCTTACGATTGTTCAGCTCACA 52
arsC2M1-R GCTGGTACCAAGCATCCATAGCTTTCTTT 52
arsC2M2-F TTGTCTAGACCAAGTTGTATTAAGCGTCCT 52
arsC2M2-R AATCTGCAGCCATGATCTGTCATAGCCAC 52
16sarsB-F ATCGTAGATCAGCCATGCTA 54
16sarsB-R GATAATCAACCCAACCAAAGT 54
arsB-F1 AGGATAATCAACCCAACCAAAGT 58
arsB-R1 CGTCCATGGAATTTACCTATTTG 58
arsB56F GGAATTTACCTATTTGGGTAT 50
arsB1185R ATATTAATGCCTTTTCTAGCC 50
cje1733F ATGTTAGGTTTTATCGATAGAT 50
cje1733R TCATGAGGCTTGATTCATTTTT 50
doi:10.1371/journal.pone.0058894.t002
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homology to ArsB in Shewanella sp. ANA-3 (32% identity;
E = 8e255) [39], Staphylococcus aureus (33% identity; E= 2e265)
[40], Escherichia coli (32% identity; E= 3e254) [41–43], and
Acidithiobacillus caldus (33% identity; E= 1e257) [44]. ArsB
contains eleven probable transmembrane helices predicted by
TMHMM2.0 (Fig. 1). Analysis of several published genome
sequences of C. jejuni strains showed that the arsB gene is conserved
and immediately downstream of the gidA gene (Fig. 2A), which
encodes a putative tRNA uridine 5-carboxymethylaminomethyl
modification enzyme [45]. RT-PCR (using primers arsBgidAF and
arsBgidAR) amplified a transcript spanning both gidA and arsB,
suggesting that these two genes form an operon and are co-
transcripted. cj0717 encodes a small protein (109 aa), which is
predicted to belong to the arsenate reductase (ArsC) family and the
Yffb subfamily. Yffb is an uncharacterized bacterial protein
encoded by the yffb gene, marginally similar to the amino-acid
sequences of classical arsenate reductases (ArsC) (Fig. 2B). cj0258
encodes an ORF of 81 aa, which is predicted to contain a helix-
turn-helix motif at aa 35–56 and belongs to the arsR family
[33,45]. To differentiate cj0258 from the asrR genes and cj0717
from the arsC gene previously identified in C. jejuni [6], we named
them as arsR3 and arsC2 in this study, respectively (Fig. 2B and C).
Role of arsB, arsC2, and arsR3 in Arsenic Resistance
To define the role of arsB, arsC2, and arsR3 in arsenic resistance
in Campylobacter, their insertional mutants were compared with the
wild-type strain NCTC 11168 for susceptibility to arsenic
compounds. According to the MIC results from the agar dilution
method, inactivation of arsB resulted in 8- and 4-fold reduction in
the MICs of arsenite and arsenate, respectively, while mutation of
arsC2 or arsR3 did not affect the MICs of arsenite and arsenate
(Table 3). All three mutants showed no changes in the MIC of
roxarsone. Chromosomal complementation of arsB restored the
MIC of arsenite to wild type, and over-expression of arsB showed
16-fold increase in the MIC of arsenite compared to the wild-type
strain. Interestingly, chromosomal complementation could not
restore the MIC of arsenate to the wild-type level and over
expression of arsB showed no change in the MIC of arsenate
compared to the wild-type strain. Furthermore, we transferred the
arsB mutation to two additional Campylobacter strains (ATCC 33560
and CB5-28) by natural transformation. Inactivation of arsB in
ATCC 33560 resulted in 8-fold reduction in the MICs of arsenite
and had no affect on the MIC of arsenate and roxarsone (Table 3).
Inactivation of arsB in CB5-28, which harbors the 4-gene ars
operon as described in a previous study [6], did not affect the
MICs of arsenite, arsenate, and roxarsone, suggesting the function
of arsB in CB5-28 is masked by the fully functional ars operon.
Mutation of the arsB did not Affect the Susceptibility to
the Other Antibiotics
To examine if arsB, arsC2, and arsR3 are associated with
resistance to other heavy metals and antibiotics, we compared the
susceptibilities of the arsB, arsC2, and arsR3 mutants with the wild-
type strain to antimonate, copper sulfate, mercury bichloride,
erythromycin, tetracycline, ethidium bromide, azithromycin,
ciprofloxacin, florfenicol, telithromycin, and clindamycin using
the broth microdilution method. The results showed no differences
between the wild type and mutants in the susceptibilities to these
compounds (data not shown), indicating that these genes do not
confer resistance to other heavy metals and antibiotics.
The arsB is Inducible by Arsenite and Arsenate
To determine if the expression of the arsB is inducible by arsenic
compounds, strain NCTC11168 was cultured in MH broth with
different concentrations of arsenite and arsenate. The transcrip-
tion levels of arsB in these cultures were compared with those
grown in MH broth without arsenic compounds using real time
qRT-PCR. As shown in Figure 3, the expression of arsB was
induced in a dose-dependent manner. At 0.5 times of MIC, both
arsenite and arsenate produced approximately 16-fold induction in
the expression of arsB. This result clearly indicates that the arsB
gene in Campylobacter is inducible by both arsenite and arsenate.
Figure 1. The membrane topologies of ArsB predicted by TMHMM. The transmembrane domains are shaded in red. The blue line indicates
loops facing inside (cytoplasma), while the pink line depicts loops facing outside (periplasmic space). The numbers at the bottom indicate the amino
acid numbers in ArsB.
doi:10.1371/journal.pone.0058894.g001
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Distribution of arsB and acr3 Genes in Campylobacter
Isolates
Data described above indicated that ArsB contributes to arsenic
resistance in C. jejuni. Additionally, Acr3 is associated with high-
level of arsenic resistance in certain Campylobacter strains [6]. We
determined the distribution of the arsB and acr3 genes in various
Campylobacter isolates of different animal origins. As shown in
Table 4, arsB was present in 76 of the 98 isolates examined in this
study, while acr3 were present in 58 of the 98 isolates. Interestingly,
all the tested strain contains at least one of the two genes.
Furthermore, arsB is more prevalent in the chicken (97.1%) and
human (92.0%) isolates than in the turkey isolates (50.0%)
(p,0.0001 and p,0.005), while the prevalence of acr3 is higher
in the turkey isolates (84.2%) than in the chicken (45.7%)
(p,0.005) and human (40.0%) (p,0.005) isolates.
Discussion
The results from this study identified ArsB involved in arsenic
resistance in C. jejuni. This conclusion is based on the following
findings: first, inactivation of arsB resulted in reduced resistance to
both arsenite and arsenate; second, complementation of the arsB
mutant restored the MIC of arsenite (but not arsenate) to that of
the wild-type strain; and third, overexpression of arsB in C. jejuni
11168 increased the MIC of arsenite by 16-fold, but did not affect
the MIC of arsenate. These results suggest that ArsB in C. jejuni
contributes resistance to arsenite, but not for arsenate. However,
arsenate can be converted to arsenite by ArsC in bacteria
including C. jejuni, where arsenite can be subsequently extruded by
ArsB and Acr3 [6]. Thus, ArsB contributes to the resistance to
arsenate in an indirect manner. These results are consistent with
the arsB findings in other bacterial species.
The ArsB in C. jejuni shares homology with the other members
of the ArsB family. ArsB is employed by many bacteria as an
arsenic detoxification method and is proposed to have 12
membrane-spanning regions [46]. ArsB appears to be an uniporter
which extrudes As(III) at a moderate rate using membrane
potential. In some cases, with the help from ArsA (ATPase), ArsB
can extrude As(III) more efficiently [5]. Several previous studies
also showed that Sb(III) is a substrate for certain ArsB transpoters
[47]. In this study, we found that the ArsB in C. jejuni does not play
a role in the resistance to other heavy metals and antibiotics. The
inability of C. jejuni ArsB to extrude Sb(III) is different from the
result reported in other bacteria [47] and suggests that the ArsB in
C. jejuni is more or less unique. Indeed, the predicted trans-
membrane topology of the ArsB in C. jejuni contains 11 trans-
membrane domains, instead of 12 of typical ArsB proteins, which
might explain the difference in substrate specificities.
The contributions of arsB to arsenic resistance vary in different
Campylobacter strains. The role of ArsB in mediating arsenic
Figure 2. Diagrams showing the genomic localizations and mutant generation of various ars genes. (A) Genomic organization of arsB
and inactivation of arsB by insertion of a choramphenicol resistance cassette. (B) Genomic localization of arsC2 and inactivation of this gene by
insertion of a kanamycin resistance cassette. (C) arsR3 and its flanking gene. Inactivation of arsR3 was accomplished by insertion of a kanamycin
resistance cassette. (D) Complementation of the arsB mutant by insertion of an extra copy of the arsB gene downstream of 16S rRNA. (E) The ars
operon identified in C. jejuni CB5-28 and inactivation of arsC by insertion of a kanamycin resistance cassette.
doi:10.1371/journal.pone.0058894.g002
Table 3. The MICs of roxarsone, arsenite and arsenate in
various C. jejuni strains as determined by the agar dilution
method*.
MIC (mg/ml)
Strains Arsenite Arsenate Roxarsone
NCTC 11168 8 512 8
11168DarsB 1(Q8) 128(Q4) 8
11168DarsC2 8 512 8
11168DarsR3 8 512 8
11168DarsBDarsC2 1(Q8) 128(Q4) 8
11168DarsB+arsB 128 128 8
11168+arsB 128(q16) 512 8
ATCC 33560 8 32 8
33560DarsB 1(Q8) 32 8
CB5-28 64 1024 64
CB5-28DarsB 64 1024 64
CB5-28DarsC 8 64 64
CB5-28DarsBDarsC 4(Q2) 64 64
*the numbers in parentheses indicate fold-changes, either increase (q) or
decrease (Q).
doi:10.1371/journal.pone.0058894.t003
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resistance to As(III) is more prominent in those strains that lack the
ars operon, such as NCTC 11168 and ATCC 33560 (Table 3). On
the contrary, inactivation of arsB in the highly resistant CB5-28
strain (containing an ars operon) did not change the MIC of
arsenite (Table 3). To test if the function of ArsB is masked by the
presence of the ars operon, we constructed an arsB and arsC double
knockout strain (CB5-28DarsBDarsC) in the CB5-28DarsC back-
ground [6]. Compared to CB5-28DarsC, CB5-28DarsBDarsC
showed 2-fold reduction in the MIC of arsenite, but not 8-fold
reduction as observed in NCTC 11168 (Table3). This could be
explained by the fact that the polar effect caused by the arsC
mutation did not totally inactivate the function of acr3 and residual
expression of acr3 still existed in the arsC mutant compared with
that in the wild-type strain [6]. Thus, the residual expression of
acr3 could still play a role in arsenite resistance. These results
suggest that the function of arsB is most likely masked in those C.
jejuni strains harboring a fully functional ars operon.
The level of arsenic resistance mediated by ArsB in C. jejuni is
not as high as that mediated by the ars operon. This could be
explained for two reasons. The published data in other bacteria
indicated that ArsB functions more efficiently when facilitated by
ArsA (ATPase) [5,16]. However, analysis of the whole genomes of
C. jejuni did not identify an arsA homology in the organism. Thus,
the lack of arsA in C. jejuni might reduce the efflux ability of ArsB.
In addition, the expression level of arsB might be another factor
affecting its contribution to arsenic resistance. As show in Table 3,
artificial overexpression of arsB in C. jejuni NCTC 11168 resulted
in a drastic increase in the resistance to arsenite, to a level that is
even higher than the resistance conferred by the ars operon. These
findings suggest that ArsB mediated arsenic resistance level in
Campylobacter is mainly dependent on the expression level of arsB.
The putative arsR (arsR3) gene did not contribute to arsenic
resistance in C. jejuni NCTC 11168. As a transcriptional repressor,
ArsR modulates the expression of ars genes through interaction
with the arsenite substrate [6]. In this study, the induction
experiment revealed that addition of arsenite or arsenate in culture
media induced the expression of arsB, and the induction was dose-
dependent (Fig. 3). Thus, we speculated that the expression of arsB
is modulated by an ArsR like regulator. However, inactivation of
arsR3, which is separated from the arsB gene on chromosome, did
not affect the expression of arsB in C. jejuni NCTC 11168,
suggesting that the expression of arsB is not modulated by arsR3
and is likely regulated by an unknown mechanism.
The putative arsC (arsC2) gene did not contribute to arsenic
resistance C. jejuni NCTC 11168. Conversion of AS(V) to AS(III)
by arsenate reductase and then extrusion by arsenite transporters
is an important detoxification mechanism used by many bacterial
organisms [6,15]. The previously characterized ars operon in C.
jejuni contains an arsC, which mediates arsenic resistance in
Campylobacter [6]. Inactivation of arsC2 in C. jejuni NCTC 11168 did
not change the susceptibility to arsenic compounds. Additionally,
we inactivated arsC2 in the arsB mutant background of C. jejuni
NCTC 11168, and the the arsB and arsC double knockout did not
further alter the resistance to arsenate compared to the arsB
mutant (data not shown), further suggesting that arsC2 is not
involved in arsenic resistance in Campylobacter.
As mentioned in the introduction, organic arsenic compounds
(roxarsone and p-arsanilic acid) are extensively used as feed
additives in the poultry industry and Campylobacter is exposed to the
selection pressure. ArsB is a putative efflux transporter for
inorganic arsenic and does not seem to directly contribute to the
resistance to roxarsone (Table 3). However, roxarsone is converted
into inorganic species such as AS(V) and AS(III) in poultry litter
[32]. Thus, ArsB is expected to facilitate Campylobacter adaptation
to the toxic effect of roxarsone in an indirect manner. To date, the
identified mechanisms of arsenic resistance in bacteria are all
related to detoxification of inorganic arsenic, and the efflux
transporters that directly extrude organic arsenic compounds have
not been reported.
Interestingly, the distribution of both arsB and acr3 in human
isolates is similar to those in chicken isolates, but differ from those
in turkey isolates (Table 4). According to a report from American
Meat Institute on April 2009, per capita consumption of chicken
was five times more than that of turkey in 2007. In addition,
poultry is the main reservoir for human C. jejuni infections. Thus,
the big portion of Campylobacter infections is probably caused by
consumption of chicken. This might explain that the presence of
ars genes in human isolates is similar to those in chicken isolates.
Furthermore, the results revealed a broad distribution of arsB and
acr3 genes (ars operon) in C. jejuni isolates of different animal origins
(Table 4) and suggest that at least one of the two genes is required
for the adaptation of Campylobacter in arsenic-rich niches. These
Figure 3. Dose-dependent induction of arsB in 11168 by
arsenite and arsenate. The concentrations of the arsenic compounds
supplemented into the culture media are labeled at the bottom of the
panel.
doi:10.1371/journal.pone.0058894.g003
Table 4. Distribution of arsB and acr3 in C. jejuni isolates of different origins.
Source of isolates Total number arsB-positive acr3-positive
Positive with both
arsB and acr3
Positive with either
arsB or acr3
Chicken 35 34 (97.1%) 16 (45.7%) 15 (42.9%) 35 (100.0%)
Turkey 38 19 (50.0%) 32 (84.2%) 13 (34.2%) 38 (100.0%)
Human 25 23 (92.0%) 10 (40.0%) 8 (32.0%) 25 (100.0%)
total 98 76 (77.6%) 58 (59.2%) 36 (36.7%) 98 (100.0%)
doi:10.1371/journal.pone.0058894.t004
Arsenic Resistance in C. jejuni
PLOS ONE | www.plosone.org 7 March 2013 | Volume 8 | Issue 3 | e58894
findings provide new insights into the adaptive mechanisms of
Campylobacter in the poultry production system.
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